default author photo

Sangwoo Park

University of Ulsan - Ulsan University Hospital

Ulsan

Korea, Republic of (South Korea)

SCHOLARLY PAPERS

1

DOWNLOADS

40

TOTAL CITATIONS

0

Scholarly Papers (1)

1.

Empagliflozin Versus Dapagliflozin and Hepatocellular Carcinoma Risk in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease and Type 2 Diabetes: A Nationwide Active-Comparator Cohort Study and Network Meta-Analysis

Number of pages: 25 Posted: 02 Jul 2026
University of Ulsan - Ulsan University Hospital, Korea University - College of Medicine, Korea University - College of Medicine, University of Ulsan - Ulsan University Hospital, University of Ulsan - Ulsan University Hospital, University of Ulsan - Ulsan University Hospital and University of Ulsan - Ulsan University Hospital
Downloads 40

Abstract:

Loading...

MASLD, Hepatocellular carcinoma, empagliflozin, dapagliflozin, SGLT2 inhibitor, diabetes mellitus